pilotitis

Patients

Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients

News

MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.